NRX Pharmaceuticals- Warrants (24/05/2026) Profit Margin

As of the most recent data (June 2026), NRXPW shows a profit margin of -691.81%. That compares with -844850.0% in the prior-year period — up 99.9% year over year. That is below the Healthcare sector average of 13.89%. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, NRXPW's profit margin is now -691.81% (was -844850.0%) — a 99.9% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether NRX Pharmaceuticals- Warrants (24/05/2026) is outperforming or lagging.

The Healthcare sector average profit margin is about 13.89%. NRX Pharmaceuticals- Warrants (24/05/2026) is at -691.81%, which is lower that average. That is roughly 5082.4% below the sector mean. Use the comparison chart on this page to see how NRXPW stacks up against individual peers as well.

That compares with -844850.0% in the prior-year period — up 99.9% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare NRX Pharmaceuticals- Warrants (24/05/2026) with peers to see if the move is company-specific or sector-wide.

Besides this profit margin page, Stockcircle has NRX Pharmaceuticals- Warrants (24/05/2026)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently -691.81%) with ownership activity and broader fundamentals.